These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

486 related articles for article (PubMed ID: 33546983)

  • 41. Analysis of the microecological mechanism of diabetic kidney disease based on the theory of "gut-kidney axis": A systematic review.
    Huang L; Wu W; Wang X
    Open Life Sci; 2024; 19(1):20220909. PubMed ID: 39119482
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut flora modulates intestinal barrier integrity but not progression of chronic kidney disease in hyperoxaluria-related nephrocalcinosis.
    Konrad L; Andersen K; Kesper MS; Kumar SV; Mulay SR; Anders HJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):86-97. PubMed ID: 31081025
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outer membrane vesicles derived from gut microbiota mediate tubulointerstitial inflammation: a potential new mechanism for diabetic kidney disease.
    Chen PP; Zhang JX; Li XQ; Li L; Wu QY; Liu L; Wang GH; Ruan XZ; Ma KL
    Theranostics; 2023; 13(12):3988-4003. PubMed ID: 37554279
    [No Abstract]   [Full Text] [Related]  

  • 44. Lanthanum hydroxide protects kidney through gut microbiota in a rat model of chronic kidney disease.
    Gao Y; Wang S; Sun L; Li B; Liu H; Bu R; Su C; Guo M; Liu Y; Zhao L; Gu C; Li X; Yuan X; Wang Q; Li G
    Pharmacol Res Perspect; 2024 Apr; 12(2):e1187. PubMed ID: 38546116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psyllium seed husk regulates the gut microbiota and improves mucosal barrier injury in the colon to attenuate renal injury in 5/6 nephrectomy rats.
    Hu D; Liu W; Yu W; Huang L; Ji C; Liu X; Lu Z
    Ren Fail; 2023 Dec; 45(1):2197076. PubMed ID: 37017261
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gut microbiota in chronic kidney disease.
    Cigarran Guldris S; González Parra E; Cases Amenós A
    Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Microbiome and Uremic Solutes.
    Zaidan N; Nazzal L
    Toxins (Basel); 2022 Mar; 14(4):. PubMed ID: 35448854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
    Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
    J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Altered Intestinal Microbiota on Chronic Kidney Disease Progression.
    Castillo-Rodriguez E; Fernandez-Prado R; Esteras R; Perez-Gomez MV; Gracia-Iguacel C; Fernandez-Fernandez B; Kanbay M; Tejedor A; Lazaro A; Ruiz-Ortega M; Gonzalez-Parra E; Sanz AB; Ortiz A; Sanchez-Niño MD
    Toxins (Basel); 2018 Jul; 10(7):. PubMed ID: 30029499
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of Gut Microbiota, Immune Imbalance, and Allostatic Load in the Occurrence and Development of Diabetic Kidney Disease.
    Han YZ; Zheng HJ; Du BX; Zhang Y; Zhu XY; Li J; Wang YX; Liu WJ
    J Diabetes Res; 2023; 2023():8871677. PubMed ID: 38094870
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between Gut Microbiota Compositions with MicrovascularComplications in Individuals with Diabetes: A Systematic Review.
    Hasani M; Pilerud ZA; Kami A; Vaezi AA; Sobhani S; Ejtahed HS; Qorbani M
    Curr Diabetes Rev; 2024; 20(10):e240124226068. PubMed ID: 38275035
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kidney-gut crosstalk in renal disease.
    Colombo I; Aiello-Battan F; Elena R; Ruiz A; Petraglia L; Musso CG
    Ir J Med Sci; 2021 Aug; 190(3):1205-1212. PubMed ID: 33216316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gut-Derived Protein-Bound Uremic Toxins.
    Graboski AL; Redinbo MR
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32932981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Microbiome modulation to correct uremic toxins and to preserve kidney functions.
    Caggiano G; Cosola C; Di Leo V; Gesualdo M; Gesualdo L
    Curr Opin Nephrol Hypertens; 2020 Jan; 29(1):49-56. PubMed ID: 31725010
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exploring the Relevance between Gut Microbiota-Metabolites Profile and Chronic Kidney Disease with Distinct Pathogenic Factor.
    Chen TH; Cheng CY; Huang CK; Ho YH; Lin JC
    Microbiol Spectr; 2023 Feb; 11(1):e0280522. PubMed ID: 36475922
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut Microbiota and Intestinal Epithelial Myd88 Signaling Are Crucial for Renal Injury in UUO Mice.
    Watanabe IKM; Andrade-Silva M; Foresto-Neto O; Felizardo RJF; Matheus MAC; Silva RC; Cenedeze MA; Honda TSB; Perandini LAB; Volpini RA; Pacheco-Silva A; Câmara NOS
    Front Immunol; 2020; 11():578623. PubMed ID: 33414781
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microbiome and Cardiovascular Disease in CKD.
    Jovanovich A; Isakova T; Stubbs J
    Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The gut-kidney-heart axis in chronic kidney disease.
    Sumida K; Kovesdy CP
    Physiol Int; 2019 Sep; 106(3):195-206. PubMed ID: 31560235
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Salivary microbiome in kidney diseases: A narrative review.
    Ramanathan K; Padmanabhan G; Gulilat H; Malik T
    Cell Biochem Funct; 2023 Dec; 41(8):988-995. PubMed ID: 37795946
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Characterizing the gut microbiota in patients with chronic kidney disease.
    Hu X; Ouyang S; Xie Y; Gong Z; Du J
    Postgrad Med; 2020 Aug; 132(6):495-505. PubMed ID: 32241215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.